StockData

Baird Medical Investment vs Jin Medical International

BDMD and ZJYL side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How BDMD and ZJYL compare

Jin Medical International grew revenue faster over the last twelve months (−12.0% versus −39.2% for Baird Medical Investment).

Jin Medical International keeps more of each dollar of sales as profit, with a net margin of 5.8% compared with −121% at Baird Medical Investment.

Jin Medical International scores higher on the StockData Score (3 against 2 for Baird Medical Investment), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricBDMDZJYL
Size and price
Share price$0.092$3.38
Change, 1 year−92.8%−34.0%
Beta (5Y)3.100.19
Employees14640
StockData Score
Total score23 (better)
Valuation score00
Growth score00
Performance score02 (better)
Health score2 (better)1
Dividend score00
Growth
Revenue growth (TTM)−39.2%−12.0% (better)
Net income growth (TTM)−319%−67.6% (better)
EPS growth (TTM)−272%−50.0% (better)
Profitability
Gross margin83.8% (better)29.2%
Operating margin−114%2.9% (better)
Net margin−121%5.8% (better)
FCF margin−6.2% (better)−18.0%
Return on equity−77.5%4.1% (better)
Return on invested capital−48.2%3.1% (better)
Financial health
Debt / equity0.22 (better)0.69
Net debt / EBITDA–−10.87
Interest coverage−72.3×–
Current ratio1.291.95 (better)
Piotroski F-score14 (better)
Ownership
Held by institutions–0.01%
Held by insiders62.0%8.3%
Short interest, % of float–0.01%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.